Prodia Diagnostic Line Tbk vs Bakrie Sumatera Plantations Tbk. — how do they compare? Prodia Diagnostic Line Tbk trades at Rp236 (market cap 428.75B, 13.83M 24h volume), while Bakrie Sumatera Plantations Tbk. trades at Rp206 (market cap 495.03B, 8.12M 24h volume). The key difference: Bakrie Sumatera Plantations Tbk. is the larger of the two by market cap, and Prodia Diagnostic Line Tbk is more actively traded (13.83M versus 8.12M). Which is the better fit depends on your goals.
| PRDL | UNSP | |
|---|---|---|
Market Cap | 428.75B | 495.03B |
Volume | 13.83M | 8.12M |
Lot | 138.27K | 81.22K |
Turnover | 3.27B | — |
Average Price | 236.62 | — |
Value | 3.27B | — |
Indicative Equilibrium Price | 236 | — |
Indicative Equilibrium Volume | 1.74K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →PT Bakrie Sumatra Plantation Tbk (the Company) was established in the Republic of Indonesia in 1911 as a joint venture between the United States and Netherland Companies under the name of NV Hollandsch Amerikaanse Plantage Maatschappij. The Company status is Domestic Investment and has 8822 employees.
Read more on UNSP →